Advertisement

Derivation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells

  • Ryohichi Sugimura
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 2005)

Abstract

Hematopoietic stem cell (HSC) transplantation is a curative treatment for hematologic malignancies and innate immunodeficiency, but its applications are limited to matched donors, and the availability of umbilical cord blood of immune types. Therefore, derivation of HSCs from patient-specific human induced pluripotent stem cells (hiPSCs) is a holy grail in regenerative medicine. However, derivation of HSCs from iPSCs has proven elusive. Here, the authors developed a method to derive hematopoietic stem and progenitor cells (HSPCs) by combining two established methods. The first method mimics embryonic development by directed differentiation of iPSCs into a cellular state termed hemogenic endothelium (HE) by stepwise exposure to different combinations of morphogens and cytokines. In the second method, transcription factors are induced in HE cells for specification into HSCs. By combining these approaches, the authors identified a set of select transcription factors that programmed HE cells into HSPCs with long-term and multilineage capacity in vivo. In this chapter, I provide an overview of this technology, technical tips, and future applications.

Key words

Pluripotent stem cells Gene regulatory network Hematopoietic stem cells 

References

  1. 1.
    Kennedy M et al (2012) T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep 2:1722–1735.  https://doi.org/10.1016/j.celrep.2012.11.003CrossRefPubMedGoogle Scholar
  2. 2.
    Pereira CF et al (2013) Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 13:205–218.  https://doi.org/10.1016/j.stem.2013.05.024CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Riddell J et al (2014) Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 157:549–564.  https://doi.org/10.1016/j.cell.2014.04.006CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ditadi A et al (2015) Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages. Nat Cell Biol 17:580–591.  https://doi.org/10.1038/ncb3161CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ditadi A, Sturgeon CM (2016) Directed differentiation of definitive hemogenic endothelium and hematopoietic progenitors from human pluripotent stem cells. Methods 101:65–72.  https://doi.org/10.1016/j.ymeth.2015.10.001CrossRefPubMedGoogle Scholar
  6. 6.
    Suzuki N et al (2013) Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol Ther 21:1424–1431.  https://doi.org/10.1038/mt.2013.71CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Amabile G et al (2013) In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 121:1255–1264.  https://doi.org/10.1182/blood-2012-06-434407CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Sandler VM et al (2014) Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature 511:312–318.  https://doi.org/10.1038/nature13547CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Lis R et al (2017) Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature 545:439–445.  https://doi.org/10.1038/nature22326CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Ryohichi Sugimura
    • 1
  1. 1.Center for iPS Cell Research and ApplicationKyotoJapan

Personalised recommendations